Stanford Nasal Spray Vaccine Shows Promise Against Respiratory Viruses and Bacteria
Researchers at Stanford Medicine have developed a nasal spray vaccine that could offer broad protection against respiratory viruses, bacteria, and allergens, according to a study published in Science. The experimental vaccine, which uses a protein called TLR4 to activate the innate immune system, showed promise in mouse trials, protecting against SARS-CoV-2, flu, pneumonia-causing bacteria, and … Read more